Cytotoxicity and P-Glycoprotein Modulating Effects of Quinolones and Indoloquinazolines from the Chinese Herb Evodia rutaecarpa

Abstract

The antimycobacterial quinolones 1-methyl-2-undecyl-4-quinolone, dihydroevocarpine and evocarpine as well as the indoloquinazoline alkaloids rutaecarpine and evodiamine - all from the Chinese medicinal herb Evodia rutaecarpa - were tested in two in vitro assays, for cytotoxicity and interaction with p-glycoprotein (p-gp). Cytotoxicity was measured in a cell proliferation assay against CCRF-CEM leukemia cells and their p-gp over-expressing subline CEM/ADR5000. An assay monitoring the p-gp-dependent accumulation of the dye calcein in porcine brain capillary endothelial cells (PBCECs) was used to study interactions of the test substances with this efflux pump. Rutaecarpine and evodiamine showed quite high toxicity with IC₅₀ values from 2.64 to 4.53 μM and were weak modulators of p-gp activity. The degrees of resistance in CEM/ADR5000 towards the saturated quinolones 1-methyl-2-undecyl-4-quinolone and dihydroevocarpine were between 3 and 4. In the calcein assay, these two quinolones were shown to be moderate modulators of p-gp activity. Evocarpine, on the other side, is not transported by p-gp, and showed only slight toxicity at the highest test concentration of 30 μM.

Evocarpines - Evodia rutaecarpa - Rutaceae - cytotoxicology - blood-brain barrier - BBB - p-glycoprotein - p-gp

References

• 1 Adams M, Wube A A, Bucar F, Bauer R, Kunert O, Haslinger E. Quinolone alkaloids from Evodia rutaecarpa: a potent new group of antimycobacterial compounds.  Int J Antimicrob Agents. 2005;  26 262-4.
• 2 Chuang W C, Cheng C M, Chang H C, Chen Y P, Sheu S J. Contents of constituents in mature and immature fruits of Evodia species.  Planta Med. 1999;  65 567-71.
• 3 Ambudkar S V, Dey S, Hrycyna C A, Ramachandra M, Pastan I, Gottesman M M. Biochemical, cellular and pharmacological aspects of the multidrug transporter.  Ann Rev Pharmacol Toxicol. 1999;  39 361-98.
• 4 Schinkel A H. P-glycoprotein, a gatekeeper in the blood-brain barrier.  Adv Drug Deliv Rev. 1999;  36 179-94.
• 5 Tamai I, Yamashita J, Kido Y. Limited distribution of new antibacterial agents into brain caused by multiple efflux transporters at the blood-brain-barrier.  J Pharmacol Exp Ther. 2000;  295 146-52.
• 6 Adams M, Kunert O, Haslinger E, Bauer R. Inhibition of leukotriene biosynthesis by quinolone alkaloids from the fruits of Evodia rutaecarpa .  Planta Med. 2004;  70 904-8.
• 7 Efferth T, Davey M, Olbrich A, Ruecker G, Gebhart E, Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.  Blood Cells Mol Dis. 2001;  28 160-8.
• 8 Finney J D. Statistical methods in biological assay. London; Charles Griffin 1978: 58-65.
• 9 Bauer B, Miller D S, Fricker G. Compound profiling for P-glycoprotein at the blood - brain barrier using a microplate screening system.  Pharm Res. 2003;  20 1170-6.
• 10 Fellner S, Bauer B, Miller D S, Schaffrik M, Fankhanel M, Spruss T. et al . Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo .  J Clin Invest. 2002;  110 1309-18.
• 11 Liao C -H, Pan S L, Guh J H, Chang Y L, Pai H C, Lin C H. et al . Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo .  Carcinogenesis. 2005;  26 968-75.
• 12 Peng J H, Zhang C E, Wei W, Hong X P, Pan X P, Wang J Z. Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats.  Neuropharmacology. 2007;  52 1521-7.